Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
United Therapeutics Corp Market Cap
From what 5 stock analysts predict, the share price for United Therapeutics Corp (UTHR) might increase by 54.75% in the next year. This is based on a 12-month average estimation for UTHR. Price targets go from $309.00 to $375.00. The majority of stock analysts believe UTHR is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
About 5 Wall Street analysts have assignedUTHR 5 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect United Therapeutics Corp to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on UTHR. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| roanna ruiz Leerink Partners | Buy | $330.0 | initiatedcoverage | Feb 5, 2024 |
| eun yang Jefferies | Buy | $315.0 | maintained | Jan 10, 2024 |
| hartaj singh Oppenheimer | Buy | $375.0 | maintained | Dec 21, 2023 |
| terence flynn Morgan Stanley | Buy | $314.0 | rated | Dec 20, 2023 |
| tiago fauth Wells Fargo | Buy | $309.0 | maintained | Dec 20, 2023 |
| jessica fye J.P. Morgan | Buy | $294.0 | maintained | Nov 2, 2023 |
| matthew kaplan Ladenburg Thalmann & Co. | Buy | $264.0 | maintained | Nov 2, 2023 |
| andreas argyrides Wedbush | Buy | $308.0 | reiterated | Nov 2, 2023 |
| andrew fein H.C. Wainwright | Buy | $300.0 | reiterated | Nov 2, 2023 |
| julian harrison BTIG | Hold | None | rated | Nov 1, 2023 |
| joseph thome TD Cowen | Buy | $270.0 | maintained | Nov 1, 2023 |
| chris shibutani Goldman Sachs | Sell | $213.0 | maintained | Oct 24, 2023 |
| greg harrison Bank of America Securities | Sell | $177.0 | reiterated | Sep 29, 2023 |
| jasper hellweg Argus Research | Buy | $280.0 | maintained | Jul 13, 2023 |
| ashwani verma UBS | Buy | $310.0 | maintained | Apr 10, 2023 |
| jessica fung BMO Capital | Buy | $280.0 | maintained | Feb 23, 2023 |
| geoff meacham Bank of America Securities | Sell | $150.0 | reiterated | Feb 22, 2023 |
| liana moussatos Wedbush | Buy | $263.0 | reiterated | Aug 4, 2022 |
| carter gould Barclays | Hold | $94.0 | upgraded | May 17, 2019 |
| joseph schwartz SVB Securities | Hold | $126.0 | maintained | Apr 3, 2017 |
When did it IPO
1999
Staff Count
0
Country
Sector/Industry
/
CEO
Market Cap
$0
In 2023, UTHR generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that UTHR's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
SPLK-USD
$154.42
TEAM-USD
$216.17
$42.33
TXN-USD
$162.4
TXG-USD
$49.11
TWKS-USD
$4.41
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
